Use of 4-oxobutanoic acid derivatives in the treatment of pathologies associated with immunological disorders

Details for Australian Patent Application No. 2008333635 (hide)

Owner Merck Patent GmbH

Inventors Miossec, Patrick; Autier, Valerie; Fabregue, Roland

Agent Davies Collison Cave

Pub. Number AU-A-2008333635

PCT Pub. Number WO2009/071161

Priority 07291449.2 03.12.07 EP

Filing date 6 November 2008

Wipo publication date 11 June 2009

International Classifications

A61K 31/192 (2006.01)

A61K 31/341 (2006.01) - not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine

A61K 31/36 (2006.01)

A61P 1/06 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 7/06 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/02 (2006.01) Drugs for immunological or allergic disorders

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

Event Publications

22 July 2010 PCT application entered the National Phase

  PCT publication WO2009/071161 Priority application(s): WO2009/071161

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008333636-Fireproof ceramic mix, fireproof ceramic molded body formed of said mix, and the use thereof

2008333624-Combustion process